Comparative analysis of binding affinities between styrene and mammalian CYP2E1 by bioinformatics approaches

被引:0
|
作者
Bing Wu
Jie Sun
Shu-Pei Cheng
Ji-Dong Gu
Ai-Min Li
Xu-Xiang Zhang
机构
[1] Nanjing University,State Key Laboratory of Pollutant Control and Resource Reuse, School of the Environment
[2] The University of Hong Kong,Laboratory of Environmental Microbiology and Toxicology, School of Biological Sciences
来源
Ecotoxicology | 2011年 / 20卷
关键词
Cytochrome P450 2E1; Styrene; Homology modeling; Molecular docking; Mammal;
D O I
暂无
中图分类号
学科分类号
摘要
Cytochrome P450 2E1 (CYP2E1) is a cytochrome P450 enzyme involved in styrene metabolism. This study compared the binding affinities between styrene and 11 mammalian CYP2E1 systems using bioinformatics methods. Firstly, amino acid sequences of CYP2E1s were obtained from the Swiss-Prot database. Then, taking the crystal structure of human CYP2E1 as a template, 3D models of the CYP2E1s of other mammals were constructed using the SWISS-MODEL program. Finally, the generated homology models were applied to calculate their docking capacities against styrene and polystyrene using the Surflex-Dock program, which could automatically dock ligands into a receptor’s ligand binding site using a protomol based approach and assess the affinity by an empirically derived scoring function. Docking experiments showed that the studied mammalian CYP2E1s had high binding affinities with styrene. For polystyrene, the dimmer of styrene has high binding affinities with CYP2E1s, however, trimer and other high polymers were found hard to be docked into the CYP2E1s. The results of this study indicated that bioinformatics approaches might be useful tools to predict styrene and polystyrene affinities with mammalian CYP2E1s.
引用
收藏
页码:1041 / 1046
页数:5
相关论文
共 50 条
  • [1] Comparative analysis of binding affinities between styrene and mammalian CYP2E1 by bioinformatics approaches
    Wu, Bing
    Sun, Jie
    Cheng, Shu-Pei
    Gu, Ji-Dong
    Li, Ai-Min
    Zhang, Xu-Xiang
    ECOTOXICOLOGY, 2011, 20 (05) : 1041 - 1046
  • [2] CYP2E1 Metabolism of Styrene Involves Allostery
    Hartman, Jessica H.
    Boysen, Gunnar
    Miller, Grover P.
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (10) : 1976 - 1983
  • [3] Cooperative effects for CYP2E1 differ between styrene and its metabolites
    Hartman, Jessica H.
    Boysen, Gunnar
    Miller, Grover P.
    XENOBIOTICA, 2013, 43 (09) : 755 - 764
  • [4] CYP2E1*5B, CYP2E1*6, CYP2E1*7B, CYP2E1*2, and CYP2E1*3 Allele Frequencies in Iranian Populations
    Shahriary, Ghazaleh Mohammadzadeh
    Galehdari, Hamid
    Jalali, Amir
    Zanganeh, Fatemeh
    Alavi, Seyed Mohammad Reza
    Aghanoori, Mohammad Reza
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (12) : 6505 - 6510
  • [5] Cooperativity in CYP2E1 metabolism of acetaminophen and styrene mixtures
    Hartman, Jessica H.
    Letzig, Lynda G.
    Roberts, Dean W.
    James, Laura P.
    Fifer, E. Kim
    Miller, Grover P.
    BIOCHEMICAL PHARMACOLOGY, 2015, 97 (03) : 341 - 349
  • [6] CYP2E1 cooperativity impacts bioactivation of mixtures of styrene and acetaminophen
    Hartman, Jessica H.
    Miller, Grover P.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [7] Investigation of bioactivation and toxicity of styrene in CYP2E1 transgenic cells
    Chung, Jou-Ku
    Yuan, Wei
    Liu, Guangxian
    Zheng, Jiang
    TOXICOLOGY, 2006, 226 (2-3) : 99 - 106
  • [8] GENETIC POLYMORPHISM IN CYP2E1: POPULATION DISTRIBUTION OF CYP2E1 ACTIVITY
    Neafsey, Pat
    Ginsberg, Gary
    Hattis, Dale
    Johns, Douglas O.
    Guyton, Kathryn Z.
    Sonawane, Babasaheb
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2009, 12 (5-6): : 362 - 388
  • [9] In vitro metabolism of styrene to styrene oxide in liver and lung of CYP2E1 knockout mice
    Carlson, GP
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2003, 66 (09): : 861 - 869
  • [10] MECHANISM OF OXIDATION BY MITOCHONDRIAL CYP2E1 DIFFERS FROM MICROSOMAL CYP2E1
    Hartman, Jessica H.
    Martin, H. Cass
    Miller, Grover P.
    DRUG METABOLISM REVIEWS, 2015, 47 : 71 - 71